Qualigen therapeutics to acquire majority stake in diagnostics technology company nanosynex

Compan ies to collaborate in the development of innovative diagnostics platform to combat “ superbugs , ” a rising global health crisis

QLGN Ratings Summary

QLGN Quant Ranking